Filing Details

Accession Number:
0001438133-20-000134
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-01 17:19:38
Reporting Period:
2020-08-28
Accepted Time:
2020-09-01 17:19:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM Surgical & Medical Instruments & Apparatus (3841) 204327508
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582970 Susan Morrison C/O Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego CA 92121
Evp & Chief Admin. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-28 7,522 $18.86 13,778 No 4 M Direct
Common Stock Disposition 2020-08-28 7,522 $114.00 6,256 No 4 S Direct
Common Stock Acquisiton 2020-08-31 6,548 $18.86 12,804 No 4 M Direct
Common Stock Disposition 2020-08-31 6,548 $114.00 6,256 No 4 S Direct
Common Stock Acquisiton 2020-09-01 5,930 $18.86 12,186 No 4 M Direct
Common Stock Disposition 2020-09-01 5,930 $114.00 6,256 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2020-08-28 7,522 $0.00 7,522 $18.86
Common Stock Stock Option Disposition 2020-08-31 6,548 $0.00 6,548 $18.86
Common Stock Stock Option Disposition 2020-09-01 5,930 $0.00 5,930 $18.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
72,478 No 4 M Direct
65,930 No 4 M Direct
60,000 No 4 M Direct
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2020.
  3. The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter.
  4. The expiration date for these options is 10 years from the date of grant.